Production of macrophage activation factor by a T-cell hybridoma.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Cellular Immunology

• Publication date

  1982-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0008-8749(82)90115-0PMID 7046954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutive production of interleukin 2 activity by a T cell hybridoma.

  1981cited by this paper
• Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A.

  1981cited by this paper
• Production of both macrophage activating and inhibiting activities by a murine T-lymphocyte hybridoma

  1981cited by this paper
• Interferon‐induced enhancement of macrophage‐mediated tumor cytolysis and its difference from activation by lymphokines

  1981cited by this paper
• Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).

  1981cited by this paper
• Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.

  1981cited by this paper
• Mechanism of action of macrophage-derived suppressor factor produced by soluble immune response suppressor-treated macrophages.

  1981cited by this paper
• T cell hybridoma-derived regulatory factors. I. Production of T cell growth factor following stimulation by concanavalin A.

  1981cited by this paper
• Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF.

  1980cited by this paper
• N-acetyl-D-galactosamine blocks activation of murine macrophages to inhibit tumor cell growth.

  1980cited by this paper
• Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.

  1978cited by this paper
• Susceptibility of malignant and normal target cells to the cytotoxic action of bone-marrow macrophages activated in vitro with the macrophage cytotoxicity factor (MCF).

  1978cited by this paper
• T-cell lines producing antigen-specific suppressor factor

  1978cited by this paper
• Characterization of the effects of endotoxin on macrophage tumor cell killing.

  1978cited by this paper
• Characterization of macrophage activation factor, a lymphokine that causes macrophages to become cytotoxic for tumor cells.

  1978cited by this paper
• Two migration inhibitory factors with different chromatographic behavior and isoelectric points.

  1977cited by this paper
• Characterization of mouse lymphocyte-derived chemotactic factor.

  1976cited by this paper
• Studies on mouse macrophage arming factor and its molecular weight.

  1976cited by this paper
• Nature of macrophage modifications induced by the macrophage activating factor(s) (MAF): effect of enzymes and temperature.

  1976cited by this paper
• Properties of antigen-specific suppressive T cell factor in the regulation of antibody response of the mouse. II. In vitro activity and evidence for the I region gene product.

  1976cited by this paper
• Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A.

  1976cited by this paper
• The response of human peripheral blood lymphocytes to phytohemagglutinin: determination of cell numbers.

  1975cited by this paper
• Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

  1975cited by this paper
• Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.

  1974cited by this paper
• Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages.

  1974cited by this paper

• Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity.

  1989cites this paper
• A dialysable acid factor from human leukocyte extracts activates tumor cell lysis mediated by human monocytes and natural killer cells.

  1989cites this paper
• Activation of natural killer cell cytotoxicity of human blood monocytes by a low molecular weight component from viscum album extract.

  1989cites this paper
• Activation of Human Monocyte and Natural Killer Cell‐Mediated Tumour Cell Killing by Two Dialysable Thymic Factors

  1986cites this paper
• Probing a repertoire of T cells responding to a mycobacterial antigen

  1985cites this paper
• Activation of macrophage tumor cytotoxicity by the synergism of two T cell‐derived lymphokines: Immune interferon (IFN‐γ) and macrophage cytotoxicity‐ inducing factor 2 (MCIF2)

  1985cites this paper
• Immunological functions of macrophages and their regulation by interferons.

  1985cites this paper
• Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon

  1985cites this paper
• Selection of Human T-Cell Hybridomas That Produce Inflammatory Lymphokines by the Emetine-Actinomycin D Method

  1985cites this paper
• Generation of human hybridomas producing migration inhibitory factor (MIF) and of murine hybridomas secreting monoclonal antibodies to human MIF.

  1985cites this paper
• Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.

  1984cites this paper
• Secretion of a macrophage-activating factor distinct from interferon-gamma by human T cell clones.

  1984cites this paper
• Biological response modifiers: preclinical evaluation and clinical activity.

  1984cites this paper
• Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.

  1984cites this paper
• Production of human/mouse hybridomas secreting a human lymphokine, osteoclast activating factor.

  1984cites this paper
• Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity.

  1984cites this paper
• Secretion of a macrophage‐activating factor distinct from interferon‐γ by human T cell clones

  1984cites this paper
• The Macrophage as a Cytotoxic Effector Cell in Mice and Humans

  1984cites this paper
• The role of lymphokines and cytokines in tumour development and surveillance

  1984cites this paper
• T-cell hybridoma-produced lymphokine that activates macrophages to suppress intracellular growth of Histoplasma capsulatum

  1984cites this paper
• Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I.

  1984cites this paper
• Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.

  1984cites this paper
• Macrophage-activating factors from different T cell clones induce distinct macrophage functions.

  1983cites this paper
• Functional identity between murine γ Interferon and macrophage activating factor

  1983cites this paper
• Immune‐interferon (IFN‐γ), Macrophage‐activating Factors (MAFs), and Colony‐stimulating Factors (CSFs) Secreted by T Cell Clones in Limiting Dilution Microcultures, Long‐term Cultures, and by T Cell Hybridomas

  1983cites this paper
• Human T-cell hybridomas producing migration inhibitory factor and macrophage activating factors.

  1983cites this paper
• Interferons as macrophage‐activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide‐stimulated human monocytes

  1983cites this paper
• Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.

  1983cites this paper
• Functional identity between murine gamma interferon and macrophage activating factor.

  1983cites this paper
• Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.

  1983cites this paper
• Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor

  1982cites this paper